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Dear colleague, 
In this seventh issue of EAVLD Newsletter you will find infor-
mation about the WAVLD Congress 2013 and the next EAVLD 
Congress 2014. We include two scientific abstracts: The first 
about a new method for safe submission of FMD-positive mate-
rial to the diagnostic lab and the second about diagnostics of 
Schmallenberg virus In Poland. Finally, there is some informa-
tion about the membership database on the EAVLD homepage 
and the present EAVLD board members.   
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Congress announcements 
WAVLD Congress 2013 
The 16th International Symposium of the 
World Association of Veterinary Laboratory 
Diagnosticians will take place in Berlin June  
5-8 2013.  
 
See http://www.wavld2013-berlin.com for 
preliminary program, venue, registration 
etc. or check the flyer: http://
www.wavld2013-berlin.com/fileadmin/
www_wavld2013_de/Home/PDF/12-09-25-
WAVLD-Flyer.pdf  
EAVLD Congress 2014 
We are happy to announce the city of Pisa 
(Tuscany) for the 2014 EAVLD Congress 
which will take place in mid-October. 
 
Pisa is known worldwide for its leaning 
tower and is a beautiful historical city. Has 
its own, well connected international air-
port  and is at 1 hour drive from Florence, 
where there is also the Peretola Airport.  
 
The venue will be the city Congress Palace 
(Palazzo dei Congressi, Via G. Matteotti 1 
www.palazzodeicongressi.pisa.it), with the 
possibility to have a main plenary room 
with up to 500 seats  and a second room 
for possible parallel sessions with 200 
seats. MV Congressi has prepared a draft 
planning and budget and has verified that 
we can manage to organize the event 
keeping the registration fees around the 
2012 figures, including a social event 
("Tuscan Night, to be held within the con-
gress venue). 
2  
 
7. Newsletter, March 2013 
EAVLD Newsletter 
Rescue of infectious Foot-and-Mouth Disease Viruses 
from preserved viral RNA 
Graham J. Belsham and Anette Bøtner 
National Veterinary Institute, Technical University of Denmark , Lindholm, 4771 Kalvehave, Denmark 
To be continued on next page.. 
without any requirement for viral proteins. 
Thus the capsid serves to protect the RNA 
when the virus is outside of cells and to 
facilitate delivery of the genome into the 
cytoplasm of cells.  
 
FMD can be controlled successfully by vac-
cination. However, there are seven distinct 
serotypes (O, A, C, Asia 1, SAT 1, SAT 2 
and SAT 3) and many subtypes have also 
been described. Vaccination against one 
serotype produces little or no protection 
against other serotypes.  
 
In countries lacking the infrastructure to 
identify rapidly the serotype of FMDV in 
samples, these can be transported to ref-
erence laboratories or similar facilities, e.g. 
the World Reference Laboratory at Pir-
bright, U.K. or DTU-Vet in Denmark, for 
characterization. However, this has re-
quired the transportation of samples con-
taining infectious FMDV which represents a 
significant bio-security hazard; it is conse-
quently expensive and often slow. More-
over, the virus samples have to be col-
lected and stored under appropriate condi-
tions, until submission, to allow virus to be 
isolated successfully in the receiving labo-
ratories. In practice, this can be difficult 
when ambient temperatures are high and 
the distances from points of collection to 
national laboratories are large and the in-
Introduction 
Foot-and-mouth disease (FMD) remains 
one of the most economically important 
diseases of farm animals globally. It is 
caused by FMD virus (FMDV) which can in-
fect a wide range of cloven-hoofed animals 
including cattle, pigs and sheep plus about 
70 wild life species, e.g. buffalo. The dis-
ease is widespread especially in Africa and 
Asia. Although Europe is normally free of 
the disease now, large numbers of out-
breaks have occurred close to its bounda-
ries, e.g. within Turkey, and hence there is 
a threat to neighboring countries. Indeed, 
Bulgaria experienced outbreaks of disease 
in 2011 due to a FMDV strain which was 
most closely related to viruses that had 
been detected within Turkey. In addition, 
there are occasional unexplained introduc-
tions, e.g. to the United Kingdom in 2001 
(which then spread to Ireland, France and 
the Netherlands)  and this resulted in very 
high economic losses due to loss of trade 
and slaughter of several million animals.  
 
FMDV is the prototypic Aphthovirus within 
the family Picornaviridae. FMDV particles 
comprise a single copy of the positive-
sense RNA genome (ca. 8400 nt in length) 
within a near spherical protein shell (or 
capsid). The viral RNA is sufficient to initi-
ate replication when introduced into cells 
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activate the very acid-labile FMDV.  From 
these preserved and inactivated samples, 
RNA was isolated and the level of FMDV 
RNA was quantified by specific real time RT
-PCR assays. RNA samples containing a 
significant level of FMDV RNA were intro-
duced into cells using electroporation 
(essentially producing transient “holes” in 
the cell membrane by an electric shock) to 
“rescue” infectious virus.  
 
Once the FMDV RNA is inside susceptible 
cells then it is able to initiate its normal in-
fectious cycle. The RNA is translated to 
make the virus proteins required to repli-
cate the RNA and to assemble new infec-
tious virus particles which can then be 
grown further in cells. 
 
This procedure has been successfully ap-
plied to samples of different FMDV sero-
types. The rescued viruses can also be 
used in virus neutralization assays (VNT) 
which are important for determining the 
suitability of available vaccine strains. The 
overall scheme is summarized in Figure 1. 
 
In addition, some of the “rescued” viruses 
have been used in challenge experiments 
within cattle housed within a high contain-
ment facility. Two viruses, a serotype O 
and a serotype Asia-1 strain, were inocu-
lated, into calves.  
 
Typical signs of FMD, including elevated 
frastructure is poor. It is therefore desir-
able to have a system where samples from 
cases of FMD can be treated at the point of 
collection to inactivate the virus infectivity 
but preserve the RNA. To perform the 
complete range of virus characterization 
procedures it is then necessary to recover 
infectious virus from the RNA within a con-
tained laboratory environment. Sequence 
analysis alone is not sufficient to determine 
the biological characteristics of the virus 
and the ability of specific vaccines to pro-
vide immunity against it. 
 
The availability of commercial reagents 
which preserve the viral RNA, in conjunc-
tion with systems for the efficient rescue of 
infectious picornaviruses from RNA, has 
permitted the development of procedures 
for the recovery of infectious FMDV from 
chemically treated clinical samples that 
contain viral RNA. It has now been shown 
that FMD viruses can be obtained from in-
activated and preserved virus samples that 
had been collected as clinical samples in 
Pakistan and Afghanistan.  
 
Rescue of infectious virus from pre-
served viral RNA 
Epithelium tissue samples, from clinically 
diseased animals, were preserved in 
RNAlater prior to transportation to DTU-
Vet, Lindholm. This reagent inactivates 
RNA degrading activity (RNAse) and it also 
has a relatively low pH (5.2) which will in-
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Fig. 1.  
temperature and vesicular lesions on the 
feet and in, and around, the mouth were 
observed in each case and the disease 
spread to in-contact animals. Thus the 
“rescued” viruses retained the pathogenic-
ity associated with this virus.   
 
Conclusion 
It is believed that the procedure described 
here should facilitate the characterization 
of FMDVs circulating in countries where the 
disease is currently endemic and thus en-
hance disease control globally.  
 
A more detailed description of this work 
has been published: 
 
Belsham GJ, Jamal SM, Tjørnehøj K, Bøt-
ner A. Rescue of foot-and-mouth disease 
viruses that are pathogenic for cattle from 
preserved viral RNA samples. PLoS One. 
2011 6(1):e14621. doi: 10.1371/
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Schmallenberg virus in Poland and the use of IPX 
method for virus identification in cell culture 
Magdalena Larska, Mirosław P. Polak, Jan F. Żmudziński 
National Veterinary Research Institute (NVRI), Virology Department, Puławy, Poland 
cated in those regions in August 2012 (Fig. 
1).  
 
Transmission of SBV into Polish cattle 
herds where the French bulls were im-
ported was confirmed by viral RNA detec-
tion in real-time RT-PCR, virus isolation fol-
lowed by immunoperoxidase staining and 
seroconversion detected by commercial 
ELISA test. Viral RNA was detected also in 
Culicoides obsoletus pools caught in the 
trap located 5 km from FR1 farm in Sep-
tember 2012 but not in midge pools from 
the same source tested in October 2011. 
While real-time RT-PCR relied on the pro-
tocol provided by Dr. Martin Beer and Dr. 
Bernd Hoffmann from FLI, Germany, who 
also kindly supplied us with positive RNA 
samples, the immunoperoxidase test (IPX) 
following virus isolation in BHK-21 cell line 
was a newly developed in-house technique. 
More detailed description of IPX is given 
below. 
 
SBV isolation test was carried out for all 
real-time RT-PCR positive samples. In 
brief, 50μl of each sample was placed in 
duplicate in 24-well microplate to adsorb 
for one hour at 37°C on approx. 80% con-
fluent BHK-21 clone 13 monolayer. Plates 
were then overlaid with GMEM supple-
mented with antibiotics and incubated at 
37°C in 5% CO2 atmosphere for 4-5 days. 
It was repeated twice (two blind passages)  
Since its emergence in Germany in Octo-
ber, 2011, a novel virus of ruminants 
called the Schmallenberg virus (SBV) has 
spread to several European countries. Po-
land so far was regarded as SBV-free 
based on limited serological and virological 
studies of native-born cattle and sheep in-
cluding aborted fetuses and calves born 
with malformations. Additionally,  the 
analysis of pooled samples of midges col-
lected for BTV monitoring from different 
regions of Poland was also negative in 
studies done at NVRI. 
 
Two outbreaks of Schmallenberg virus 
(SBV) infection occurred in West Pomera-
nia and Silesia provinces of Poland, after 
two bulls imported from France (FR1 and 
FR2) were introduced into two herds lo-
Fig. 1. Geographic location of two SBV-
positive herds (FR1 and FR2).  
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with the last incubation shortened to 48-72 h. Following fixation with 20% acetone, the cells 
were incubated with SBV antiserum collected from FR1 bull in 1:10 dilution for 1 h and sub-
sequently with rabbit anti-cow serum conjugated with horseradish peroxidase. After adding 
a solution of 3-amino-9-ethylcarbazole (AEC) and HRP substrate, the plates were examined 
microscopically for the presence of virus specific staining. Uninfected BHK-21 cells served as 
the negative control for IPX staining (Fig. 2).  
Fig. 2. IPX staining of SBV positive (A) and mock-inoculated BHK-21 monolayer cells (B). 
New membership database 
 
To simplify contact between members and the administration of membership a new mem-
bership database has been launched on the EAVLD homepage www@eavld.com. To reach 
the members database you have to log in and click on the button at the top of the page. 
Through this database you have the possibility to contact other members if they have not 
blocked this option. Please note that this database is not yet complete as some member’s 
information remains to be transferred. So, don’t worry if you don’t find yourself there. The 
work with making the database complete is in progress. 
 
Next to the database button you can find the buttons “my details” and “my profile”. The first 
one allows you to change some of the information given in the membership application while 
the second allows you to change log-in details for your account. However, you cannot 
change your name in “my details” unless you contact the secretary.  
 
The membership application form has also changed and is now on-line and can be reached 
through the public page. New applicants fill in the form and submit. New members are sub-
sequently guided to the pay-pal payment button. Other payment options are also avail-
able.  After completing the payment the application is reviewed by the secretary and the 
treasurer. If everything is in order the full membership will be granted and log-in details 
sent out.  
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for proteins and lipopolysaccharide, molecular 
cloning and preparation and purification of re-
combinant proteins.  
 
Further, Lars Ole performed studies on patho-
genesis and development of infection models in 
pigs. Vaccinology has also been a key research 
activity that included development of experi-
mental vaccines, subunit vaccines and autoge-
nous vaccines, against pleuropneumonia, 
edema disease and exudative epidermitis in 
pigs, as well as evaluation of vaccines and 
therapeutic antisera in experimental animal 
models and in clinical field trials. Current em-
ployment as Senior Advisor comprise supervis-
ing routine diagnostic methods, approving and 
interpreting results of laboratory analyses and 
advising veterinarians. Lars Ole was elected as 
member of the EAVLD board in 2012  
Lars Ole Andresen was 
born in 1961 in Ames, Iowa, 
USA, and graduated as 
M.Sc. from the Technical 
University of Denmark in 
1987. While employed at 
the Veterinary Division of 
the pharmaceutical com-
pany Nordisk Droge A/S Lars Ole finished his 
post graduate education as Industrial Re-
searcher (~PhD) in 1990. Since 1990 Lars Ole 
has been employed at the institution that today 
is the National Veterinary Institute in Denmark. 
His research has comprised development of 
ELISAs and PCR for research, surveillance and 
diagnosis of infectious diseases, characteriza-
tion of disease causing bacterial agents, anti-
gens and virulence factors, including develop-
ment of detection and purification procedures 
Department of Virology. In 1994 he was 
awarded Fulbright Fellowship at the University 
of Nebraska, Lincoln, U.S., where he spent 13 
months doing research on BVDV thermosensi-
tive mutants and learning modern molecular 
biology based laboratory methods. In 1998 he 
did his PhD on BVDV including experimental 
inoculation in calves and isolation of field iso-
lates in cell culture followed by molecular biol-
ogy typing. In 2010 Miroslaw was awarded the 
habilitation degree (associate professor) based 
on his work on BSE in Polish cattle. 
 
In 2012 he was involved in the preparation of 
the second EAVLD congress, held in Kazimierz 
Dolny, July 1-4, 2012, where he was elected 
the second vice-president of the EAVLD. 
 
Miroslaw Polak was born 
in 1964 in Pulawy 
(Poland), is married and 
has two daughters (Zuza 
and Gabi). He studied Vet-
erinary Medicine in Lublin, 
where he graduated in 
1990. Between 1990 and 
1992 he worked at the 
Animal Hygiene Department of the University 
of Agriculture in Lublin, where he had classes 
with students and worked on modern breeding 
systems for pigs with special emphasis on wel-
fare issues of sows and newborn piglets. 
 
In 1992 he started working at the National Vet-
erinary Research Institute in Pulawy at the       
New board members elected at the general meeting in 
Poland 2012 
To be continued on next page.. 
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Gian Luca Autorino was 
born on March 24, 1956. 
Gian Luca studied Veteri-
nary Medicine in Perugia 
and graduated in February 
1980. He received a Mas-
ter in Management of 
Health Institutions at the 
LUISS University in 1997.  
Since 1984 Gian Luca held 
a position at the Instituto Zooprofilattico Speri-
mentale of Lazio and Toscana where, from 
1995 to the present, is head of the Virology 
Unit and from 1999 to the present is responsi-
ble for the National Reference Centre for 
Equine Diseases. His major expertise and re-
search are in classical virology and in preven-
tion and control of animal viral diseases and 
zoonoses.  
With particular reference to present project 
proposal on Equine Infectious Anaemia dr. Gian 
Luca Autorino is project leader of a funded re-
search programme on “Evaluation of new diag-
nostic screening protocol applied to the na-
tional surveillance programme and verification 
of the concordance among the methods avail-
able; Study of the principal risk factors investi-
gated in independent geographical clusters of 
infection; Clinical, immunological and virologi-
cal evaluations of naturally infected animals”. 
Dr. Gian Luca Autorino is member of the Euro-
pean Society for Veterinary Virology, 2005-
2007 member of the board of the Italian Soci-
ety of Veterinary Diagnostics (SIDILV), and 
from 2008 to 2011 President of the same asso-
ciation. He became a member of the EAVLD 
board in 2012. 
 
Continued... 
In 2012 she was given the opportunity to take 
on the role of Laboratory Resource Manager, 
being part of the Laboratory Services Depart-
ment management team, and taking on re-
sponsibility for two laboratories in the Midlands 
region of the UK.  Whilst at AHVLA Kirsty has 
been involved in diagnostic test development 
for TB culture and molecular assays, MAP mo-
lecular assays, Campylobacter fetus speciation 
assay development.  
 
She has also been involved in assessment of 
MALDI-ToF for bacterial identification, and 
LAMP assay development, and development of 
computer LIMS systems to aid laboratory re-
porting and data collection. Kirsty Line was 
elected as EAVLD board member in 2012. 
 
Kirsty Line obtained a 
BSc in Biochemistry from 
the University of Wales, 
Aberystwyth in 2000, and 
a PhD in protein structure 
and function from Univer-
sity of Exeter in 2004.   
 
She then undertook research and teaching in a 
number of protein structure and function areas, 
including the investigation of proteins from 
helminth parasites, including Haemonchus con-
tortus, and Fasciola hepatica.   
 
Kirsty joined Animal Health and Veterinary 
Laboratories Agency in 2009, taking on the role 
of Work Group Leader in the regional labora-
tory Starcross, in the South West of England.  
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Board members elected at the general meeting in 
Holland 2010 
To be continued on next page.. 
on classical swine fever. There he also finished 
his PhD on swine influenza, which he originally 
started at the Animal Health Service. Later on 
he also became project leader for African swine 
fever and Aujeszky's disease.  
 
He remained interested in swine influenza, be-
ing part of the ESNIP European projects on 
swine influenza, working on avian influenza in 
swine during and shortly after the AI outbreak 
in the Netherlands (2003), and recently work-
ing on pandemic (2009) H1N1 in swine. 
 
He was the first secretary of EAVLD from 2009 
and organised the first EAVLD congress in Le-
lystad 2010. Willie was elected as the second 
president of EAVLD in 2012. 
Willie Loeffen was born on 
July 24, 1964 in Oss (the 
Netherlands). Willie studied 
Veterinary Medicine in 
Utrecht, graduating in 1991. 
Between 1991 and 2001 he 
worked at the Animal Health 
Service in Boxtel, carrying 
out field research on Au-
jeszky's disease, respiratory problems in swine 
in general and swine influenza more specifi-
cally. He also supported swine veterinarians in 
the field, with respiratory diseases as his main 
expertise. 
 
In 2001 he started working at the Central Vet-
erinary Institute in Lelystad as project leader 
After his PhD, he spent one year at the Royal 
Veterinary and Agricultural University in Copen-
hagen (Denmark), and later six months at the 
FRS Marine Laboratory in Aberdeen (Scotland, 
UK). 
 
In 2002 he got a permanent position as Associ-
ate Professor in Animal Health in the Veterinary 
Faculty (Universidad Complutense de Madrid). 
And he still is involved in the diagnosis of bac-
terial diseases, now at the Veterinary Clinical 
Hospital. 
 
He became member of the EAVLD Board in 
2009, and was elected at the first General As-
sembly in Lelystad 2010. 
 
 
 
Jose A. Garcia quali-
fied from the Veterinary 
Faculty (Universidad 
Complutense) in Madrid 
in 1987. Just as he fin-
ished he joined the Ani-
mal Health Department 
in the same Faculty 
where he has been working since then.  
 
There he also carried out his PhD thesis on dif-
ferent aspects of the pathogenesis of listeriosis. 
He also worked in the diagnostic service of the 
Department from the beginning, mainly bacte-
rial diseases of domestic animals, but has also 
been involved in different cases of wild ani-
mals. It was working for this service as he 
started to work in fish diseases, field in which 
he has been mainly involved since then.  
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Frederik Widén was born in 
1958, graduated from Vet 
school in 1986 and spent a few 
years in large animal practice 
before starting at SVA (the Na-
tional Veterinary Institute) in 
Uppsala, Sweden. At SVA he 
started at the pathology depart-
ment before moving to bacteriology and finally 
to virology. The PhD work, concerning Porcine 
Cytomegalovirus and supervised by Dr. Mal-
colm Banks, was mostly carried out in England 
where he lived together with his family for 
three years. After the PhD his work has been 
dedicated to research on Classical Swine Fever 
and Hepatitis E virus but also to West Nile Fe-
ver and emerging viral infections. He has al-
ways, since starting at SVA, been involved in 
routine diagnostic work on a regular basis. He 
has been treasurer of the EAVLD since 2009. 
 
Martin Beer was born on 
19th of August 1966 in Er-
langen, is married and has 
two children (Julius and 
Nils). He studied veterinary 
medicine at the Veterinary 
Faculty of the Ludwig-
Maximilians-University in 
Munich, Germany. He re-
ceived a DVM degree and finished his thesis 
about the role of T-cell immunity in BVDV in-
fection at the same university. He held a posi-
tion at the Institute for Medical Microbiology in 
Munich, where he was awarded the 
‘Habilitation’, shortly after moving to the Frie-
drich-Loeffler-Institut (FLI) as head of the Na-
tional Reference Laboratory for Bovine Herpes-
virus type 1.  
Martin Beer is director of the Institute of Diag-
nostic Virology at the FLI, Insel Riems since 
2004, and within his institute many of the Ger-
man  National Reference Laboratories, e.g. for 
FMD, CSF and AI are situated. Martin Beer has 
been working with several animal viruses like 
Pestiviruses, Bovine Herpesvirus Type 1, Avian 
Influenza Virus and Bluetongue Virus with spe-
cial emphasis on the development of novel vac-
cines and modern diagnostic systems. 
Sven Erik Jorsal was born 
in 1950 in southern Jutland, 
Denmark. He is married to 
Jytte (also a vet.) and they 
have three children and one 
grandchild. Sven Erik studied 
Veterinary Medicine in Co-
penhagen and graduated in 
1976.  
 
He worked as veterinary practitioner for 4 
years. From 1980 he worked at the Royal Vet-
erinary and Agricultural University in Copenha-
gen, where he finished his PhD in 1984. The 
next 5 years he worked at the Federation of 
Danish Pig Producers and Slaughterhouses, 
Laboratories in Roskilde and Kjellerup. From 
1989 he has worked at the National Veterinary 
Institute, Technical University of Denmark 
(former the Danish Veterinary Laboratory) as 
senior scientist and veterinary consultant.  
 
The work since 1980 has mainly concerned epi-
demiology and diagnostics of infectious dis-
eases in production animals and the research 
topics were primarily diseases of the respira-
tory and digestive systems of pigs.  
 
To be continued on next page.. 
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ELISA laboratory at Pharma-Bio Research, a 
Clinical Pharmaceutical and Biomedical Re-
search centre for the registration of pharma-
ceutical compounds at the FDA. 
 
He became head of one of the laboratory units 
within the Virology Department at ID-DLO 
(Lelystad) in 1996. Gerard fulfilled his PhD 
study on the role of viruses in the aetiology of 
bovine mastitis in 2002.  
 
From 2005 on, he is senior scientist in Molecu-
lar Biology and Virology at the Dutch Animal 
Health Service in Deventer. Since 2001, he is 
also active as veterinary consultant in national 
and international projects.  
Gerard Wellenberg was 
born on July 20, 1958. Gerard 
studied Medical Microbiology 
in Deventer, The Netherlands.  
 
He started his active carrier 
at the Regional Medical 
Health Laboratory and the 
Regional Animal Health Ser-
vices in 1977 and 1980, respectively. During 
this period, he studied Immunology and Bio-
chemistry at the Open University in The Neth-
erlands. In the period 1992 – 1994, he studied 
Medical Biology at the University of Groningen.  
 
In the next two years, he was setting up an 
Andrew Soldan qualified 
from the Royal Veterinary 
College in London in 1984.  
After 2 years in mixed prac-
tice he undertook an MSc in 
Tropical Veterinary Medicine 
at Edinburgh and then 
worked in Malawi for 4 years 
helping to set up an epidemiology unit, per-
forming diagnostic work and undertaking re-
search into tick borne diseases. On returning to 
the UK he worked as a Veterinary Investigation 
Officer at the Veterinary Laboratories Agency 
(VLA) Bury St Edmunds lab before going back 
into mixed practice in Devon.  After 3 years in 
practice he rejoined the VLA as Regional Test 
Manager for the Southern region of the UK.   
 
During 2001 he was responsible for coordinat-
ing various laboratories undertaking FMD serol-
ogy following the UK outbreak.  In late 2001 he 
was appointed as Programme Manager for In-
ternational Trade and Head of Laboratory Test-
ing with responsibility for all testing activities at 
the 16 VLA sites.  In 2006 he became the first 
Commercial Programme manager for the VLA 
with a role to maximise the value of Intellectual 
Property generated from VLA research and to 
grow VLA’s work with Industry.  In 2009 he 
was awarded the degree of Doctor of Veteri-
nary Medicine and Surgery by the University of 
Edinburgh.  Since late 2009 he has been Vet-
erinary Director for the VLA. He is married to 
Brenda (also a vet), has 3 children and lives in 
Devon. In 2009 he became the first president 
of the EAVLD. 
